Literature DB >> 28685652

The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.

Lisanne En Manson1, Cathelijne H van der Wouden1, Jesse J Swen1, Henk-Jan Guchelaar1.   

Abstract

Keywords:  PREPARE study; U-PGx consortium; adverse drug reactions; block-randomized controlled trial; implementation; panel; pharmacogenomics; pre-emptive

Mesh：

Year:  2017        PMID： 28685652     DOI： 10.2217/pgs-2017-0093

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  8 in total

Review 1.  Essential Characteristics of Pharmacogenomics Study Publications.

Authors:  Caroline F Thorn; Michelle Whirl-Carrillo; Houda Hachad; Julie A Johnson; Ellen M McDonagh; Mark J Ratain; Mary V Relling; Stuart A Scott; Russ B Altman; Teri E Klein
Journal:  Clin Pharmacol Ther       Date:  2019-01       Impact factor: 6.875

2.  Longitudinal exposure of English primary care patients to pharmacogenomic drugs: An analysis to inform design of pre-emptive pharmacogenomic testing.

Authors:  James E Kimpton; Iain M Carey; Christopher J D Threapleton; Alexandra Robinson; Tess Harris; Derek G Cook; Stephen DeWilde; Emma H Baker
Journal:  Br J Clin Pharmacol       Date:  2019-12-13       Impact factor: 4.335

Review 3.  Clinical implementation of drug metabolizing gene-based therapeutic interventions worldwide.

Authors:  Evangelia Eirini Tsermpini; Zeina N Al-Mahayri; Bassam R Ali; George P Patrinos
Journal:  Hum Genet       Date:  2021-10-01       Impact factor: 4.132

4.  PharmaKoVariome database for supporting genetic testing.

Authors:  Jungeun Kim; Jae-Pil Choi; Min Sun Kim; Jong Bhak
Journal:  Database (Oxford)       Date:  2022-10-18       Impact factor: 4.462

Review 5.  Translating Pharmacogenetics and Pharmacogenomics to the Clinic: Progress in Human and Veterinary Medicine.

Authors:  Deirdre P Campion; Fiona J Dowell
Journal:  Front Vet Sci       Date:  2019-02-11

6.  The Three Ps: Psychiatry, Pharmacy, and Pharmacogenomics, a Brief Report From New Zealand.

Authors:  Simran D S Maggo; Kyra L V Sycamore; Allison L Miller; Martin A Kennedy
Journal:  Front Psychiatry       Date:  2019-09-20       Impact factor: 4.157

7.  Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years.

Authors:  Alberto M Borobia; Irene Dapia; Hoi Y Tong; Pedro Arias; Mario Muñoz; Jair Tenorio; Rafael Hernández; Irene García García; Gema Gordo; Elena Ramírez; Jesús Frías; Pablo Lapunzina; Antonio J Carcas
Journal:  Clin Transl Sci       Date:  2017-11-28       Impact factor: 4.689

8.  Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study.

Authors:  Cathelijne H van der Wouden; Stefan Böhringer; Erika Cecchin; Ka-Chun Cheung; Cristina Lucía Dávila-Fajardo; Vera H M Deneer; Vita Dolžan; Magnus Ingelman-Sundberg; Siv Jönsson; Mats O Karlsson; Marjolein Kriek; Christina Mitropoulou; George P Patrinos; Munir Pirmohamed; Emmanuelle Rial-Sebbag; Matthias Samwald; Matthias Schwab; Daniela Steinberger; Julia Stingl; Gere Sunder-Plassmann; Giuseppe Toffoli; Richard M Turner; Mandy H van Rhenen; Erik van Zwet; Jesse J Swen; Henk-Jan Guchelaar
Journal:  Pharmacogenet Genomics       Date:  2020-08       Impact factor: 2.000
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.